Alnylam Pharmaceuticals

Senior Medical Director, Clinical Research - Neurodegeneration

Alnylam Pharmaceuticals$305K — $413K *
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • MD with research background or MD/PhD and a track record of peer-reviewed publications
  • 10+ years of industry or equivalent clinical academic experience
  • Proven ability to lead Phase 2/3 clinical programs, particularly in interactions with Health Authorities
  • Familiarity with clinical research concepts, trial design, and regulatory guidelines
  • Strong communication skills for effective presentation of complex ideas
  • Demonstrated superior judgment and problem-solving abilities
  • Exceptional leadership and collaboration skills in a matrix environment
  • Experience in biotech/pharma partnerships is a plus
  • Ability to thrive in a fast-paced entrepreneurial setting.

Responsibilities

  • Lead and provide strategic direction for clinical programs
  • Create innovative and actionable drug development strategies to achieve regulatory approvals
  • Oversee safety and trial conduct to ensure compliance
  • Advise Research on all clinical implications in decision-making
  • Collaborate with multiple departments to ensure integrated development plans
  • Accountable for all Clinical Research timelines and deliverables
  • Supervise the creation of major written deliverables, including regulatory documents
  • Review and sign off on controlled documents and protocols as needed
  • Influence stakeholders in high-impact and visible settings.

Benefits

  • Comprehensive medical, dental, and vision insurance
  • Life and disability insurance
  • 401(k) plan with generous company match
  • Paid time off, wellness days, and holidays
  • Flexible spending and health savings accounts
  • Lifestyle reimbursement program
  • Generous family resources and leave
  • Two company-wide recharge breaks
Full Job Description
Overview

The successful candidate's primary role will be to drive the pipeline forward through leadership of clinical development programs. While the primary focus responsibility will be as clinical lead physician on Alnylam's Huntington's program, the role may support across a range of therapeutic areas and all stages of development may be required as pipeline assets evolve. He/she is expected to play a leading and influencing role in the overall clinical development strategies and drive progress and operational excellence for associated clinical trials. In addition, this role will include interaction with Alnylam's research group, helping to advise the team on the clinical development feasibility of novel targets and the design of proof-of-concept studies. This work will also involve extensive consultation and collaboration with external experts. It is expected that additional opportunities will arise to lead bench-to-bedside early phase clinical development programs.

The Senior Director, Clinical Research, will work in a matrix organization across Regulatory, Biostatistics, Clinical Operations, Preclinical, Commercial & QA teams to ensure fully harmonized and integrated development strategies. He/she will be a key Alnylam Development spokesperson at external meetings, including regulatory interactions and scientific meetings.

This position is hybrid and will be primarily located at our Cambridge, MA headquarters or Maidenhead, UK location.

Key Responsibilities

  • Be the strategic leader providing a strong, clear voice for the clinical programs
  • Develop creative but realistic approaches to drug development and lead clinical efforts to secure global regulatory approvals
  • Oversight of trial conduct and safety
  • Provide strategic consultation and guidance to Research on all decisions that have significant clinical components and implications.
  • Collaborate closely with Preclinical, Regulatory Affairs, Medical Affairs and Commercial to ensure tight strategic integration of product development plans
  • Be accountable via Clinical Research and Operations for all relevant timelines and deliverables
  • Drive/supervise all major written deliverables (regulatory submissions, original articles, abstracts), and presentation materials
  • Be responsible (as appropriate in line with SOPs) for final review and sign off with respect to all controlled documents including protocols, IBs, informed consent forms
  • Influence internal and external audiences in a high impact, highly visible fashion


Qualifications

  • MD with strong research background or MD PhD, with a track record of successful research support and peer review publications. Board Certification (or equivalent) or specialist training is highly desirable; drug development experience in neurology (Huntington's Disease) would be a great advantage, but not essential
  • 10+ years industry experience or equivalent clinical academic experience
  • Sound scientific and clinical judgment
  • Successful track record of leading Phase 2/3 clinical programs (preferably in Huntington's drug development), including major interactions with Health Authorities
  • Familiarity with concepts of clinical research and clinical trial design, including biostatistics, regulatory agency organization, guidelines, and practices
  • Ability to effectively present ideas and document complex medical/clinical concepts in both written and oral communication
  • History of solving problems while exhibiting superior judgment and a balanced, realistic understanding of issues
  • Outstanding leadership and collaboration skills working within a matrix environment.
  • Experience and knowledge of working with biotech/pharma partner(s) a plus
  • Thrives in highly entrepreneurial biotech environment and embraces Alnylam's culture of science, passion and urgency.


U.S. Pay Range

$305,700.00 - $413,700.00

The pay range reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus or sales incentive) and an annual long-term incentive award (e.g., equity).

Alnylam's robust Total Rewards package is designed to support your overall health and well-being. We offer comprehensive benefits including medical, dental, and vision coverage, life and disability insurance, a lifestyle reimbursement program, flexible spending and health savings accounts and a 401(k)with a generous company match. Eligible employees enjoy paid time off, wellness days, holidays, and two company-wide recharge breaks. We also offer generous family resources and leave. Our commitment to your well-being reflects our belief that caring for our people fuels the impact we create together.

Learn more about these and additional benefits offered by Alnylam by visiting the Benefits section of the Careers website: https://www.alnylam.com/careers

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals is a biotechnology company that focuses on RNA interference (RNAi) therapeutics. The company's products are designed to silence specific genes that cause diseases. Alnylam's pipeline includes products for the treatment of genetic, cardio-metabolic, and hepatic infectious diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Learn more about Alnylam Pharmaceuticals
Size
1,665 employees
Market Cap
$28.7 billion
Industry
Net Income
-$858.2 million
Founded
2002
5 Year Trend
+78.1%
Revenue
$492.8 million
NASDAQ

Similar Jobs

More Jobs at Alnylam Pharmaceuticals

More Pharmaceuticals & Biotech Jobs

Find similar Senior Medical Director, Clinical Research - Neurodegeneration jobs: